Moderna forecasts 15% to 25% 2026 revenue growth as it targets $8.1B to $8.3B year-end cash
At a glance
- $MRNA today+5.27%last $254.19
- Since it broke−3.49%$MRNA from the first trade after publication
- 52-week range5.0% below high$22.28 – $267.50
- In the headline$8.1 billionAmount
- Coverage4 this week21 in 30 days · about its usual pace
- Sector scannerCalmHealth Care
What it means
- What to watch: There is a hard number in this story (15%) — the interesting part is how it compares with the last few like it.
- How the stock is trading: $MRNA +5.27% in the latest session.
- Timing: It dropped mid-session, while New York was open, so the move beside it may already include the market's first reaction.
Where the stock stands
$MRNA last changed hands at $254.19, +5.27% on the session, 5.0% below its 52-week high of $267.50 and 1041% above its low of $22.28 — within a tenth of its 52-week high. Over the year it has ranged 1101% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $MRNA page.
How much coverage it is getting
In the last 30 days Wook has filed 21 stories about $MRNA — 4 of them this week. At its 30-day pace you would expect about 5 a week, so this week is about normal. Across those stories the wording ran 24% bullish, 52% neutral and 24% bearish. This one reads bullish, so it sits in a small minority of the run. 10 came from Seeking Alpha; the rest came from other outlets, so this is a story more than one newsroom is chasing. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
What to watch next
The $MRNA page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $MRNA sits from its high, or how this week's coverage stacks up.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 6, 2026. $MRNA has moved -3.49% ($263.37 to $254.19). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.